#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2340615	B	Selectivity ratio of IC50 for human DHFR to Candida glabrata DHFR		11		assay format	Scientific Literature
2.	ALA2340616	B	Inhibition of human DHFR	Homo sapiens	11		single protein format	Scientific Literature
3.	ALA2340617	B	Selectivity ratio of IC50 for human DHFR to Candida albicans DHFR		11		assay format	Scientific Literature
4.	ALA2340618	B	Inhibition of Candida glabrata DHFR	Nakaseomyces glabratus	11		assay format	Scientific Literature
5.	ALA2340620	B	Inhibition of Candida albicans DHFR	Candida albicans	11		single protein format	Scientific Literature
6.	ALA3530563	B	Inhibition of Staphylococcus aureus DHFR assessed as reduction in rate of NADPH consumption	Staphylococcus aureus	9		single protein format	Scientific Literature
7.	ALA3530564	F	Antimicrobial activity against Staphylococcus aureus	Staphylococcus aureus	8		organism-based format	Scientific Literature
8.	ALA3530565	P	Kinetic solubility of the compound		6		small-molecule physicochemical format	Scientific Literature
9.	ALA3530566	A	Stability in mouse liver microsomes assessed as parent compound remaining at 5 ug/ml after 1 hr at 37 degC by reverse phase HPLC method	Mus musculus	4		assay format	Scientific Literature
10.	ALA3530567	A	Half life in mouse liver microsomes at 5 ug/ml at 37 degC by reverse phase HPLC method	Mus musculus	5		assay format	Scientific Literature
11.	ALA3530568	A	Drug metabolism in mouse liver microsomes assessed as pyridyl-N-oxidation at 5 ug/ml after 1 hr at 37 degC by reverse phase HPLC method	Mus musculus	4		assay format	Scientific Literature
12.	ALA3530569	A	Drug metabolism in mouse liver microsomes assessed as demethylation at 5 ug/ml after 1 hr at 37 degC by reverse phase HPLC method	Mus musculus	4		assay format	Scientific Literature
13.	ALA3530752	A	Drug metabolism in mouse liver microsomes assessed as oxidation on pyrimidinyl substructure at 5 ug/ml after 1 hr at 37 degC by reverse phase HPLC method	Mus musculus	4		assay format	Scientific Literature
14.	ALA3530753	A	Drug metabolism in mouse liver microsomes assessed as bis-oxidation at 5 ug/ml after 1 hr at 37 degC by reverse phase HPLC method	Mus musculus	4		assay format	Scientific Literature
15.	ALA3530754	A	Stability in pH 1.2 simulated gastric fluid at 5 ug/ml after 24 hrs at 37 degC by reverse phase HPLC method		4		tissue-based format	Scientific Literature
16.	ALA3530755	P	Stability in water at 5 ug/ml after 24 hrs at 37 degC by reverse phase HPLC method		4		small-molecule physicochemical format	Scientific Literature
17.	ALA3529131	A	Stability in pH 7.4 simulated intestinal fluid at 5 ug/ml after 24 hrs at 37 degC by reverse phase HPLC method		4		assay format	Scientific Literature
18.	ALA3529333	A	Drug metabolism in mouse liver microsomes assessed as 3-(4-(2,4-diamino-6-methylpyrimidin-5-yl)but-3-yn-2-yl)-5-(pyridin-4-yl)phenol formation at 10 ug/ml by LC-MS/MS method	Mus musculus	1		assay format	Scientific Literature
19.	ALA3529334	A	Drug metabolism in mouse liver microsomes assessed as 4-(3-(4-(2,4-diamino-6-methylpyrimidin-5-yl)but-3-yn-2-yl)-5-methoxyphenyl)pyridine 1-oxide at 10 ug/ml by LC-MS/MS method	Mus musculus	1		assay format	Scientific Literature
20.	ALA3705794	B	Enzyme Inhibition Assay: Heterocyclic analogs of propargyl-linked inhibitors of the third generation analogs were evaluated in enzyme inhibition assays, assessed for S. aureus and S. pyogenes inhibition, and evaluated for mammalian cell toxicity.	Staphylococcus aureus	15		single protein format	BindingDB Database